Dr. Norberto Mancera, MD

Dr. Mancera practices at Florida Eye Specialists And Cataract Institute in Brandon, Florida.

Dr. Mancera's NPI, 1750776696, was assigned on March 30, 2015. Dr. Mancera graduated from USF Health Morsani College of Medicine in 2015. Dr. Mancera holds Florida license ME149927.

Dr. Mancera's primary practice is Florida Eye Specialists and Cataract Institute, at 403 Vonderburg Dr Suite 101 Suite 101, Brandon, FL 33511-5501. The practice phone is (813) 681-1122.

Dr. Mancera's primary practice is Florida Eye Specialists And Cataract Institute in Brandon, Florida. Dr. Mancera is also affiliated with BayCare St. Joseph's Hospital. Dmand AI also links Dr. Mancera to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mancera practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mancera's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mancera is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Mancera's licenses on file in 3 states: Florida, Illinois and Wisconsin.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma, inflammation of iris, secondary membranaous cataract surgery and shingles among the conditions Dr. Mancera treats.

CMS data shows 4,626 Medicare services from Dr. Mancera across 25 procedure codes in 2024, for 529 Medicare patients. Medicare paid $394,720 for them.

CMS counts 529 Medicare patients who saw Dr. Mancera in 2024. The largest group is 65 to 74, with 250 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mancera's median patient age at 67, with 63% women.

In 2024, Dr. Mancera wrote 1,219 Medicare Part D claims for 586 patients. 90% of them were for generic drugs. CMS names the drug for 1,120 of them, across 16 drugs with 11 or more claims each, at $21,556 in total drug cost. In 2023, CMS named 1,095 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Mancera for performance year 2024, reported as part of a group. Dr. Mancera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 168 procedures of melanoma (skin cancer) excision by Dr. Mancera, more than 96% of the clinicians it reports for that procedure.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Mancera, published from 2012 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Eyelids and Postoperative Complications. Dr. Mancera has published most often in Ophthalmic Plast Reconstr Surg. Dr. Mancera's most frequent co-authors are Curtis E. Margo, MD, Jasmina Bajric, MD and Ramesh Somayajula Ayyala, MD.

CMS Open Payments shows 122 general payments to Dr. Mancera from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 42% of the total. Horizon Pharma plc paid the most, $7,487.

Dr. Mancera graduated from USF Health Morsani College of Medicine in 2015.

Dr. Mancera is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.